Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
about
Pharmacological treatment options for mast cell activation diseaseEosinophilia in Hematologic DisordersHypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update.Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.Oral mucosa lesions in hypereosinophilic syndrome--an update.Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.Management of hypereosinophilia in tropical settings.Bone morbidity in chronic myeloproliferative neoplasms.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.Idiopathic hypereosinophilic syndrome involving thoracic spine.Successful treatment of steroid resistant hypereosinophilic syndrome with low-dose CsAWorld Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management.Hypereosinophilic syndrome in childhood: clinical and molecular features of two cases.Hypereosinophilic syndrome with central nervous system involvement: Two case reports and literature review.Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.Guideline for the investigation and management of eosinophilia.
P2860
Q26748784-987F1F0A-30DC-4A70-8A6F-EA2697EEFD84Q26799611-EEA32B82-A7D2-49D3-BB79-2D11FD8F007FQ33620407-07CFAD10-9E9A-43D9-B7A9-225E08874DC0Q34171747-618668C7-A50B-49B9-9260-D2B0877DF961Q34547831-90AED4E3-FFF9-4B20-A868-D7CB17AD1453Q37056671-472B9986-5644-45F5-8A72-C924CBDB98DDQ37854888-D139F629-78C7-479E-A15E-CFB3B14C5476Q37901437-71C9BF95-4134-4A0E-954F-4BA7897DF741Q38038509-CAC41D29-8B8F-4186-A8D9-15172C2EDD74Q38191834-C204A39A-BC1E-4304-A839-24D0B9868D18Q38327667-5BC36844-90C5-4D47-B880-6C5B212ACD40Q38513219-1FC35F7E-D013-4E28-9055-6D8950E3E93CQ38739710-07975826-C7B2-4D6B-898C-DB029B848034Q38788064-5F11186C-74AA-4AAA-87AA-7E09D431FE27Q40960033-4C08F3A6-4F1C-4816-8E2D-E14690172BC2Q41876524-4F9DDB98-88E0-47E1-AAA0-1A2901C620CCQ46026437-868D569C-CC1A-471C-9EC1-E996E05E8E16Q46042993-3F02B291-3186-4B91-97B6-04920E241EA0Q47261160-AB913385-2CD8-4642-B33D-4C2889F960BEQ53587646-E171C3B4-A56C-4D33-9028-F0921C70B2CAQ55059996-92C4D231-47EA-4167-832D-0B12424248B6
P2860
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@ast
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@en
type
label
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@ast
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@en
prefLabel
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@ast
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@en
P2860
P356
P1433
P1476
Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
@en
P2093
J H Butterfield
P2860
P356
10.1159/000085560
P577
2005-01-01T00:00:00Z